Cystatin C is a biomarker for predicting acute kidney injury in patients with acute-on-chronic liver failure

World Journal of Gastroenterology

Volumn 19, Issue 48, 2013, Pages 9432-9438

  Wan, Zhi Hong ^a   Wang, Jian Jun ^a   You, Shao Li ^a   Liu, Hong Ling ^a   Zhu, Bing ^a   Zang, Hong ^a   Li, Chen ^a   Chen, Jing ^a   Xin, Shao Jie ^a  

^a BEIJING 302 HOSPITAL   (China)

Author keywords

Acute kidney injury; Acute on chronic liver failure; Creatinine; Cystatin C; Prediction

Indexed keywords

CREATININE; CYSTATIN C; SODIUM;

ACUTE KIDNEY FAILURE; ACUTE ON CHRONIC LIVER FAILURE; ADULT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULUS FILTRATION RATE; HEPATITIS B; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; UREA NITROGEN BLOOD LEVEL;

ACUTE KIDNEY INJURY; ACUTE-ON-CHRONIC LIVER FAILURE; CREATININE; CYSTATIN C; PREDICTION;

ACUTE KIDNEY INJURY; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CREATININE; CYSTATIN C; EARLY DIAGNOSIS; END STAGE LIVER DISEASE; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER FAILURE, ACUTE; LOGISTIC MODELS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; NEPHELOMETRY AND TURBIDIMETRY; ODDS RATIO; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TIME FACTORS; UP-REGULATION;

EID: 84891377924     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v19.i48.9432     Document Type: Article

References (35)

1. Sarin SK, Kumar A, Almeida JA, Chawla YK, Fan ST, Garg H, de Silva HJ, Hamid SS, Jalan R, Komolmit P, Lau GK, Liu Q, Madan K, Mohamed R, Ning Q, Rahman S, Rastogi A, Riordan SM, Sakhuja P, Samuel D, Shah S, Sharma BC, Sharma P, Takikawa Y, Thapa BR, Wai CT, Yuen MF. Acuteon-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). Hepatol Int 2009; 3: 269-282 [PMID: 19669378 DOI: 10.1007/ s12072-008-9106-x]
2. Ke WM, Ye YN, Huang S. Discriminant function for prognostic indexes and probability of death in chronic severe hepatitis B. J Gastroenterol 2003; 38: 861-864 [PMID: 14564632 DOI: 10.1007/s00535-003-1162-3]
3. You SL, Rong YH, Zhu B, Zhang AM, Zang H, Liu HL, Li DZ, Wan ZH, Xin SJ. Changing etiology of liver failure in 3,916 patients from northern China: a 10-year survey. Hepatol Int 2013; 7: 714-720 [DOI: 10.1007/s12072-013-9424-5]
4. Cárdenas A, Ginès P. Acute-on-chronic liver failure: the kidneys. Curr Opin Crit Care 2011; 17: 184-189 [PMID: 21311322 DOI: 10.1097/MCC.0b013e328344b3da]
5. Jalan R, Gines P, Olson JC, Mookerjee RP, Moreau R, Garcia-Tsao G, Arroyo V, Kamath PS. Acute-on chronic liver failure. J Hepatol 2012; 57: 1336-1348 [PMID: 22750750 DOI: 10.1016/ j.jhep.2012.06.026]
6. Moreau R, Jalan R, Gines P, Pavesi M, Angeli P, Cordoba J, Durand F, Gustot T, Saliba F, Domenicali M, Gerbes A, Wendon J, Alessandria C, Laleman W, Zeuzem S, Trebicka J, Bernardi M, Arroyo V. Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. Gastroenterology 2013; 144: 1426-137, 1426-137, [PMID: 23474284 DOI: 10.1053/j.gastro.2013.02.042]
7. Leithead JA, Ferguson JW, Bates CM, Davidson JS, Lee A, Bathgate AJ, Hayes PC, Simpson KJ. The systemic inflammatory response syndrome is predictive of renal dysfunction in patients with non-paracetamol-induced acute liver failure. Gut 2009; 58: 443-449 [PMID: 19001057 DOI: 10.1136/ gut.2008.154120]
8. Ricci Z, Cruz D, Ronco C. The RIFLE criteria and mortality in acute kidney injury: A systematic review. Kidney Int 2008; 73: 538-546 [PMID: 18160961 DOI: 10.1038/sj.ki.5002743]
9. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007; 11: R31 [PMID: 17331245 DOI: 10.1186/cc5713]
10. Bellomo R, Kellum JA, Ronco C. Defining acute renal failure: physiological principles. Intensive Care Med 2004; 30: 33-37 [PMID: 14618231 DOI: 10.1007/s00134-003-2078-3]
11. Cholongitas E, Shusang V, Marelli L, Nair D, Thomas M, Patch D, Burns A, Sweny P, Burroughs AK. Review article: renal function assessment in cirrhosis-difficulties and alternative measurements. Aliment Pharmacol Ther 2007; 26: 969-978 [PMID: 17877504 DOI: 10.1111/j.1365-2036.2007.03443.x]
12. Daugherty NA, Hammond KB, Osberg IM. Bilirubin interference with the kinetic Jaffé method for serum creatinine. Clin Chem 1978; 24: 392-393 [PMID: 627087]
13. Shlipak MG, Coca SG, Wang Z, Devarajan P, Koyner JL, Patel UD, Thiessen-Philbrook H, Garg AX, Parikh CR. Presurgical serum cystatin C and risk of acute kidney injury after cardiac surgery. Am J Kidney Dis 2011; 58: 366-373 [PMID: 21601336 DOI: 10.1053/j.ajkd.2011.03.015]
14. Gerbes AL, Gülberg V, Bilzer M, Vogeser M. Evaluation of serum cystatin C concentration as a marker of renal function in patients with cirrhosis of the liver. Gut 2002; 50: 106-110 [PMID: 11772976]
15. Wagner D, Kniepeiss D, Stiegler P, Zitta S, Bradatsch A, Robatscher M, Müller H, Meinitzer A, Fahrleitner-Pammer A, Wirnsberger G, Iberer F, Tscheliessnigg K, Reibnegger G, Rosenkranz AR. The assessment of GFR after orthotopic liver transplantation using cystatin C and creatinine-based equations. Transpl Int 2012; 25: 527-536 [PMID: 22369048 DOI:10.1111/j.1432-2277.2012.01449.x]
16. Randers E, Erlandsen EJ. Serum cystatin C as an endogenous marker of the renal function--a review. Clin Chem Lab Med 1999; 37: 389-395 [PMID: 10369108]
17. Dharnidharka VR, Kwon C, Stevens G. Serum cystatin C is superior to serum creatinine as a marker of kidney function: a meta-analysis. Am J Kidney Dis 2002; 40: 221-226 [PMID: 12148093]
18. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, Price CP. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995; 47: 312-318 [PMID: 7731163]
19. Seo YS, Jung ES, An H, Kim JH, Jung YK, Kim JH, Yim HJ, Yeon JE, Byun KS, Kim CD, Ryu HS, Um SH. Serum cystatin C level is a good prognostic marker in patients with cirrhotic ascites and normal serum creatinine levels. Liver Int 2009; 29: 1521-1527 [PMID: 19725889 DOI: 10.1111/ j.1478-3231.2009.02105.x]
20. Sharawey MA, Shawky EM, Ali LH, Mohammed AA, Hassan HA, Fouad YM. Cystatin C: a predictor of hepatorenal syndrome in patients with liver cirrhosis. Hepatol Int 2011; Epub ahead of print [PMID: 21484118 DOI: 10.1007/s12072-011-9266-y]
21. Liver Failure and Artificial Liver Group, Chinese Society of Infectious Diseases, Chinese Medical Association; Severe Liver Diseases and Artificial Liver Group, Chinese Society of Hepatology, Chinese Medical Association. [Diagnostic and treatment guidelines for liver failure]. Zhonghua Gan Zang Bing Zazhi 2006; 14: 643-646 [PMID: 16995974]
22. Chinese Society of Infectious Diseases and Parasitology; Chinese Society of Hepatology. Management scheme of diagnostic and therapeutic criteria of viral hepatitis. Zhonghua Gan Zang Bing Zazhi 2000; 8: 324-329
23. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron 1976; 16: 31-41 [PMID: 1244564]
24. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130: 461-470 [PMID: 10075613]
25. Hoek FJ, Kemperman FA, Krediet RT. A comparison between cystatin C, plasma creatinine and the Cockcroft and Gault formula for the estimation of glomerular filtration rate. Nephrol Dial Transplant 2003; 18: 2024-2031 [PMID: 13679476]
26. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012; 367: 20-29 [PMID: 22762315 DOI: 10.1056/NEJMoa1114248]
27. Wasmuth HE, Kunz D, Yagmur E, Timmer-Stranghöner A, Vidacek D, Siewert E, Bach J, Geier A, Purucker EA, Gressner AM, Matern S, Lammert F. Patients with acute on chronic liver failure display "sepsis-like" immune paralysis. J Hepatol 2005; 42: 195-201 [PMID: 15664244 DOI: 10.1016/ j.jhep.2004.10.019]
28. Mookerjee RP, Dalton RN, Davies NA, Hodges SJ, Turner C, Williams R, Jalan R. Inflammation is an important determinant of levels of the endogenous nitric oxide synthase inhibitor asymmetric dimethylarginine (ADMA) in acute liver failure. Liver Transpl 2007; 13: 400-405 [PMID: 17318866 DOI:10.1002/lt.21053]
29. Francoz C, Durand F. A new look at renal dysfunction in the cirrhotic patient. Crit Care 2012; 16: 118 [PMID: 22385933 DOI:10.1186/cc11207]
30. Sjöström P, Tidman M, Jones I. Determination of the production rate and non-renal clearance of cystatin C and estimation of the glomerular filtration rate from the serum concentration of cystatin C in humans. Scand J Clin Lab Invest 2005; 65: 111-124 [PMID: 16025834]
31. Salerno F, Gerbes A, Ginès P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Gut 2007; 56: 1310-1318 [PMID: 17389705]
32. Papadakis MA, Arieff AI. Unpredictability of clinical evaluation of renal function in cirrhosis. Prospective study. Am J Med 1987; 82: 945-952 [PMID: 3578363]
33. Demirtaş S, Bozbaş A, Akbay A, Yavuz Y, Karaca L. Diagnostic value of serum cystatin C for evaluation of hepatorenal syndrome. Clin Chim Acta 2001; 311: 81-89 [PMID: 11566167]
34. Fawdry RM, Gruenewald SM, Collins LT, Roberts AJ. Comparative assessment of techniques for estimation of glomerular filtration rate with 99mTc-DTPA. Eur J Nucl Med 1985; 11: 7-12 [PMID: 3899658]
35. Lewis R, Kerr N, Van Buren C, Lowry P, Sandler C, Frazier OH, Powers P, Herson J, Corriere J, Kerman R. Comparative evaluation of urographic contrast media, inulin, and 99mTc-DTPA clearance methods for determination of glomerular filtration rate in clinical transplantation. Transplantation 1989; 48: 790-796 [PMID: 2815251]